[1] Abou Ziki MD, Mani A. Metabolic syndrome:genetic insights into disease pathogenesis. Curr Opin Lipidol, 2016; 27, 162-71. doi:  10.1097/MOL.0000000000000276
[2] Michel MC, Brunner HR, Foster C, et al. Angiotensin Ⅱ type 1 receptor antagonists in animal models of vascular, cardiac, metabolic and renal disease. Pharmacol Ther, 2016; 164, 1-81. doi:  10.1016/j.pharmthera.2016.03.019
[3] Qian X, Guo D, Zhou H, et al. Interactions between PPARG and AGTR1 gene polymorphisms on the risk of hypertension in Chinese han population. Genet Test Mol Biomarkers, 2018; 22, 90-7. doi:  10.1089/gtmb.2017.0141
[4] Martínezrodríguez N, Posadasromero C, Cardoso G, et al. Association of angiotensin Ⅱ type 1-receptor gene polymorphisms with the risk of developing hypertension in Mexican individuals. J Renin Angiotensin Aldosterone Syst, 2012; 13, 133-40. doi:  10.1177/1470320311419175
[5] Chaves FJ, Pascual JM, Rovira E, et al. Angiotensin Ⅱ AT1 receptor gene polymorphism and microalbuminuria in essential hypertension. Am J Hypertens, 2001; 14, 364-70. doi:  10.1016/S0895-7061(00)01284-X
[6] Zhu X, Yan D, Cooper RS, et al. Linkage disequilibrium and haplotype diversity in the genes of the renin-angiotensin system:findings from the family blood pressure program. Genome Res, 2003; 13, 173-81. doi:  10.1101/gr.302003
[7] Hai B, Xie H, Guo Z, et al. Gene-Gene Interactions among Pparα/δ/γ Polymorphisms for Apolipoprotein (Apo) A-I/Apob Ratio in Chinese Han Population. Iran J Public Health, 2014; 43, 749-59. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=Doaj000004067547
[8] Chan KH, Niu T, Ma Y, et al. Common genetic variants in peroxisome proliferator-activated receptor-γ (PPARG) and type 2 diabetes risk among Women's Health Initiative postmenopausal women. J Clin Endocrinol Metab, 2013; 98, E600-4. doi:  10.1210/jc.2012-3644
[9] Guo SX, Guo H, Ma RL, et al. Analysis of the haplotype and linkage disequilibrium of PPARγ gene polymorphisms rs3856806, rs12490265, rs1797912, and rs1175543 among patients with metabolic syndrome in Kazakh of Xinjiang Province. Genet Mol Res, 2014; 13, 8686-94. doi:  10.4238/2014.October.27.9
[10] Auclair M, Vigouroux C, Boccara F, et al. Peroxisome proliferator-activated receptor-γ mutations responsible for lipodystrophy with severe hypertension activate the cellular renin-angiotensin system. Arterioscler Thromb Vasc Biol, 2013; 33, 829-38. doi:  10.1161/ATVBAHA.112.300962